In quick turn, ten23 already looking to expand Visp fill-finish site

Josh Sullivan

Last October, ten23 health acquired a Visp, Switzerland, site from swissfillon, a local pharma known for its fill-finish operations. On Monday, the CDMO

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

In quick turn, ten23 already looking to expand Visp fill-finish site

Josh Sullivan

Sign up to read this article for free.

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

CagriSema’s weight loss data disappointed. What does Novo do next?

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

CMS explains what went into its first round of drug price negotiations

Novo Nordisk’s once-daily hemophilia drug Alhemo approved in US

Califf, on his way out at FDA, predicts agency tug-of-war between Ramaswamy and RFK Jr.

In quick turn, ten23 al­ready look­ing to ex­pand Visp fill-fin­ish site

Josh Sullivan

Sign up to read this article for free.

more like this

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

In quick turn, ten23 already looking to expand Visp fill-finish site

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

CagriSema’s weight loss data disappointed. What does Novo do next?

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

CMS explains what went into its first round of drug price negotiations

Novo Nordisk’s once-daily hemophilia drug Alhemo approved in US

Califf, on his way out at FDA, predicts agency tug-of-war between Ramaswamy and RFK Jr.